Table 3.
Ulcer outcome | Adjustment status | Change in outcome per 1 mmol/L increase in FCBG |
Equivalent effect size | P value | |
Estimate | 95% CI | ||||
Ulcer area (cm2) * | Unadjusted | 0.010 | –0.041 to 0.062 | 0.004 | 0.69 |
Adjusted† | 0.004 | −0.024 to 0.032 | 0.001 | 0.77 | |
Log(ulcer area +0.01) * | Unadjusted | 0.134 | 0.049 to 0.214 | 0.10 | 0.002** |
Adjusted† | 0.114 | 0.020 to 0.194 | 0.08 | 0.0145* | |
Rate of absolute change (cm2/week) * | Unadjusted | 0.011 | −0.018 to 0.041 | 0.01 | 0.45 |
Adjusted‡ | 0.009 | −0.014,0.032 | 0.01 | 0.70 | |
Rate of relative change (%/week-1) * | Unadjusted | 5.7 | 1.1 to 10.3 | 0.06 | 0.015* |
Adjusted‡ | 5.7 | 1.1 to 10.3 | 0.06 | 0.015* | |
HR§ | Unadjusted | 0.90 | 0.74 to 1.10 | N/A | 0.31 |
Adjusted ¶ | 0.88 | 0.71 to 1.08 | N/A | 0.21 |
*Mixed linear regression, additive change reported.
†Adjusted for baseline value and time since Visit 1.
‡Adjusted for time since Visit 1 only.
§Cox regression, multiplicative change reported.
¶Adjusted for baseline ulcer area.
FCBG, fasting capillary blood glucose.